Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.685 USD | -3.16% | -2.59% | -35.80% |
May. 09 | Cue Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 08 | Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.80% | 84.64M | |
+9.29% | 114B | |
+11.35% | 104B | |
-13.84% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.22% | 17.89B | |
+7.68% | 14.28B | |
+34.47% | 12.55B |
- Stock Market
- Equities
- CUE Stock
- News Cue Biopharma, Inc.
- Cue Biopharma Head, Neck Cancer Treatment Candidate Granted FDA Fast Track Designation; Shares Rise